Skip to content

READ-POAF Pilot Studies Postoperative Atrial Fibrillation After Cardiac Surgery

READ-POAF Pilot Study. The Use of the Reveal XT as Device for Postoperative Atrial Fibrillation Detection After Cardiac Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01530750
Enrollment
40
Registered
2012-02-10
Start date
2012-03-31
Completion date
2014-02-28
Last updated
2012-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

postoperative atrial fibrillation, internal loop recorder, risk factors, coronary artery bypass surgery

Brief summary

Postoperative atrial fibrillation after coronary artery bypass grafting will be monitored up to 1 year after the procedure by implanting a Reveal XT internal loop recorder two weeks before the surgery. Frequency, burden, and possible risk factors will be described. During the operation direct contact epicardial mapping will be performed and tissue samples will be collected to identify an electrophysiological and a structural substrate for development of AF.

Detailed description

Background of the study: Postoperative atrial fibrillation (POAF) after cardiac surgery is a common (1 in 4) complication and associated with morbidity and mortality. Not all episodes of AF are noticed and detected, especially after discharge. several studies have shown high mortality in POAF patients, suggesting a progression in AF frequency. Objective of the study: To investigate the real incidence and burden of POAF. Afterwards a risk stratification of POAF is made. To identify a structural and electrophysiological substrate for the development of POAF and new onset AF during follow up. Study design: 140 patients will receive a Reveal device. After 3 and 12 months data will be subtracted from the device. 100 of these patient will undergo additional mapping and tissue biopsies during operation. Study population: All patients undergoing cardiac surgery without a history of AF and without a pacemaker will be invited to participate in the study. Primary study parameters/outcome of the study: Incidence of POAF until 3 months after CABG. Secondary study parameters/outcome of the study: Incidence of POAF until 12 months after CABG. Determine risk factors for early and late POAF. Detect pre-operative (unnoticed) episodes of AF. Determine a substrate for development of AF. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: There is a small risk of minor complications (hemorrhage and infection of the pocket).The device can be explanted easily if necessary. Ther is a burden of the im- and explantation of the device (local anesthesia, approx. 20 minutes). Patient will have to visit the out-hospital clinic twice. The operation will be prolonged by 30 minutes due to mapping.

Interventions

None listed

Sponsors

Maastricht University Medical Center
CollaboratorOTHER
Catharina Ziekenhuis Eindhoven
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Undergoing non emergency surgery * Sinus rhythm on initial visit

Exclusion criteria

* History of atrial fibrillation * Internal pacemaker

Design outcomes

Primary

MeasureTime frameDescription
atrial fibrillation (AF)3 monthsfrequency, frequency distribution, and burden of AF

Secondary

MeasureTime frameDescription
atrial fibrillation (AF)12 monthsfrequency, frequency distribution, burden of AF, AF substrate

Countries

Netherlands

Contacts

Primary ContactSander Bramer, MD
sander.bramer@cze.nl+31402398680

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026